Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$851M |
| 2 |
Apple
AAPL
|
+$663M |
| 3 |
UnitedHealth
UNH
|
+$206M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$559M |
| 2 |
Broadcom
AVGO
|
+$224M |
| 3 |
United Rentals
URI
|
+$189M |
| 4 |
CRH
CRH
|
+$177M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Financials | 17.11% |
| 3 | Industrials | 13.24% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Milestone Pharmaceuticals
MIST
$143M
| $70.6K | ﹤0.01% |
39,450
-34,254
| -46% | -$55.6K |
|
3302
Franklin Wireless
FKWL
$27.2M
| $70.3K | ﹤0.01% |
23,499
| – | – |
|
|
CBIO
3303
Crescent Biopharma
CBIO
$555M
| $69.5K | ﹤0.01% |
+232
| New | +$69.3K |
|
3304
Data Storage Corp
DTST
$6.78M
| $69.2K | ﹤0.01% |
+12,098
| New | +$52.6K |
|
3305
Alpha Teknova
TKNO
$271M
| $69.2K | ﹤0.01% |
27,351
-192
| -0.7% | -$596 |
|
3306
Verrica Pharmaceuticals
VRCA
$90.4M
| $69K | ﹤0.01% |
1,165
| – | – |
|
|
BRFS
3307
DELISTED
BRF SA
BRFS
| $68.1K | ﹤0.01% |
20,893
+1,062
| +5% | +$3.13K |
|
3308
Veritone
VERI
$97.6M
| $68.1K | ﹤0.01% |
12,947
-12
| -0.1% | -$28 |
|
|
LITS
3309
Lite Strategy Inc
LITS
$33.6M
| $67.8K | ﹤0.01% |
16,962
+6,016
| +55% | +$27.3K |
|
3310
Prelude Therapeutics
PRLD
$402M
| $67.8K | ﹤0.01% |
14,305
| – | – |
|
3311
Virgin Galactic
SPCE
$329M
| $66.2K | ﹤0.01% |
2,237
-233
| -9% | -$8.46K |
|
3312
Anixa Biosciences
ANIX
$121M
| $66.1K | ﹤0.01% |
21,177
| – | – |
|
|
VTYX
3313
DELISTED
Ventyx Biosciences
VTYX
| $66.1K | ﹤0.01% |
12,010
-5,013
| -29% | -$22.9K |
|
|
ASRT
3314
DELISTED
Assertio
ASRT
| $63.3K | ﹤0.01% |
4,400
| – | – |
|
3315
Arts-Way Manufacturing Co
ARTW
$11.3M
| $63.1K | ﹤0.01% |
30,943
-1,256
| -4% | -$2.58K |
|
3316
SurgePays
SURG
$5.43M
| $62.9K | ﹤0.01% |
16,333
+5,901
| +57% | +$39.4K |
|
3317
Patriot National Bancorp
PNBK
$128M
| $62.1K | ﹤0.01% |
16,980
| – | – |
|
|
BMTX
3318
DELISTED
BM Technologies, Inc.
BMTX
| $61.3K | ﹤0.01% |
37,122
-91
| -0.2% | -$175 |
|
3319
SOPHiA GENETICS
SOPH
$483M
| $60.9K | ﹤0.01% |
+12,354
| New | +$59.7K |
|
3320
Oramed Pharmaceuticals
ORMP
$169M
| $60.4K | ﹤0.01% |
+20,696
| New | +$57.9K |
|
3321
Lineage Cell Therapeutics
LCTX
$277M
| $59.9K | ﹤0.01% |
40,449
| – | – |
|
|
IAUX
3322
i-80 Gold Corp
IAUX
$1.16B
| $59.7K | ﹤0.01% |
+44,547
| New | +$64.5K |
|
3323
Vor Biopharma
VOR
$1.18B
| $59.1K | ﹤0.01% |
1,246
+222
| +22% | +$9.75K |
|
3324
Sypris Solutions
SYPR
$44.2M
| $58.3K | ﹤0.01% |
36,695
-15,337
| -29% | -$29.6K |
|
3325
PharmaCyte Biotech
PMCB
$6.44M
| $58.2K | ﹤0.01% |
24,563
-4,744
| -16% | -$10.3K |
|
Similar funds
Dimensional Fund Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Dimensional Fund Advisors held 3,470 positions worth $369B, up 7.9% from $342B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 58 new positions and exited 83, leaving the 3,470-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 8,775,487 shares worth $37.8M.
- Dimensional Fund Advisors added most to NVIDIA in Q1 2024, an estimated $851M increase.
- Dimensional Fund Advisors's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $559M.
- Dimensional Fund Advisors fully exited Textainer Group Holdings limited in Q1 2024, selling an estimated $161M.
- Dimensional Fund Advisors's ten largest holdings make up 13% of its $369B portfolio in Q1 2024.
- Dimensional Fund Advisors opened 58 new positions and closed 83 in Q1 2024.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $369B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.